Get started Log in

BLU — BELLUS Health Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid Cap

Market Cap
$1.87bn
Enterprise Value
$1.56bn
Revenue
$0.02m

Brief: Bellus Health Says Completed Enrollment In Phase 2 Relief Trial Of Blu-5937 For Refractory Chronic Cough
19/03/2020 11:06
Nasdaq Trade Halt Market Wide Circuit Breaker Halt: LEVEL 1 AT 08:42 AM
09/03/2020 13:42
Brief: Bellus Health Inc Files For Stock Shelf Of Up To $200 Million
20/12/2019 22:02
Brief: Bellus Health Reports Qtrly Loss Per Share C$0.18
14/11/2019 13:09
Cowen starts coverage of Bellus Health with "outperform", says co is undervalued
30/09/2019 14:04
U.S. RESEARCH ROUNDUP- Apple, Bellus Health, Emerson Electric
30/09/2019 08:48
Brief: Orbimed Advisors Reports A Stake Of 8.9% In BELLUS Health As Of Sept. 9
18/09/2019 23:17
Brief: Bellus Health Announces Exercise Of Over-Allotment Option In Connection With Underwritten Public Offering Of Common Shares
17/09/2019 14:03
NASDAQ RESUMED
05/09/2019 15:02
Brief: Bellus Health Announces Pricing Of US$70 Mln Public Offering In Canada And The United States
05/09/2019 12:37
NASDAQ TRADE HALT REASON NOT AVAILABLE
05/09/2019 09:00
Brief: BELLUS Health Announces The Launch Of A $60 Mln Public Offering Of Common Shares In Canada And U.S.
03/09/2019 13:07
Brief: Bellus Health Announces Share Consolidation
15/08/2019 12:10
Brief: Bellus Health Says First Patient Enrolled In Mid-Stage Study Of Chronic Cough Treatment
30/07/2019 13:11
Brief: Bellus Health Presents Phase 1 Data For Blu-5937
21/05/2019 17:17
Brief: Bellus Health Provides Update On Its Chronic Cough Drug Candidate Blu-5937, Reports Qtrly Results
08/05/2019 22:57
Brief: Bellus Health Announces Clearance Of U.S. IND For BLU-5937 Phase 2 Study
03/04/2019 12:20
Canada Research Roundup: Cronos Group, Conifex Timber, Park Lawn
28/03/2019 09:50
Brief: BELLUS Health Announces Pricing Of $35 Mln Public Offering Of Common Shares
11/12/2018 14:51
Brief: Bellus Health Announces Overnight Marketed Equity Offering
10/12/2018 22:35